MP50-16 ONCOLOGICAL OUTCOMES FOLLOWING ROBOTIC POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR CANCER: A WORLDWIDE MULTICENTER STUDY

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP50-16 ONCOLOGICAL OUTCOMES FOLLOWING ROBOTIC POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION FOR TESTICULAR CANCER: A WORLDWIDE MULTICENTER STUDY Alireza Ghoreifi, Anirban Mitra, Ashish Khanna, Jordan Rich, George McClintock, Fady Baky, Zachary Mcdowell, Matthew Ho, Jacob Roberts, Farshad Sheybaee Moghaddam, Taseen Haque, Inderbir Gill, Scott Eggener, James Porter, Nariman Ahmadi, Reza Mehrazin, John Sfakianos, Aditya Bagrodia, Sudhir Rawal, John Ward, and Hooman Djaladat Alireza GhoreifiAlireza Ghoreifi More articles by this author , Anirban MitraAnirban Mitra More articles by this author , Ashish KhannaAshish Khanna More articles by this author , Jordan RichJordan Rich More articles by this author , George McClintockGeorge McClintock More articles by this author , Fady BakyFady Baky More articles by this author , Zachary McdowellZachary Mcdowell More articles by this author , Matthew HoMatthew Ho More articles by this author , Jacob RobertsJacob Roberts More articles by this author , Farshad Sheybaee MoghaddamFarshad Sheybaee Moghaddam More articles by this author , Taseen HaqueTaseen Haque More articles by this author , Inderbir GillInderbir Gill More articles by this author , Scott EggenerScott Eggener More articles by this author , James PorterJames Porter More articles by this author , Nariman AhmadiNariman Ahmadi More articles by this author , Reza MehrazinReza Mehrazin More articles by this author , John SfakianosJohn Sfakianos More articles by this author , Aditya BagrodiaAditya Bagrodia More articles by this author , Sudhir RawalSudhir Rawal More articles by this author , John WardJohn Ward More articles by this author , and Hooman DjaladatHooman Djaladat More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003298.16AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: The feasibility and safety of robotic approach for post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) has been previously shown by our group. The aim of this study is to evaluate the oncological outcomes of robotic PC-RPLND. METHODS: In this retrospective study, we included patients who underwent robotic PC-RPLND at nine academic centers across the world between 2011 and 2022. Patients’ characteristics, pathological findings, and oncological outcomes were reviewed. RESULTS: A total of 137 patients with a median age of 29 (IQR 25, 36) years were included. The baseline features and clinicopathological findings are shown in Table 1. BEP (bleomycin, etoposide, cisplatin) was the main chemotherapy regimen (80%) and 12 patients (9%) received salvage chemotherapy. Twelve cases (9%) were electively converted to open. Median estimated blood loss, operative time, and length of hospital stay were 100 mL, 5 hours, and 2 days, respectively. Final pathology revealed necrosis/fibrosis in 59 (43%), pure teratoma in 64 (47%), and viable germ cell tumor in 14 (10%) patients. Among patients with residual viable tumor, those with pN2,3 non-seminoma received chemotherapy and the others were followed closely. With a median follow-up of 21 (IQR 8, 49) months, seven patients (5%) had disease recurrence, of whom 3 (2%) were in-field (Table 2). 2-year recurrence free survival was 93%. Median time to recurrence was 11 months. No port-site recurrence or carcinomatosis was identified. Two (1.5%) cancer-related deaths were recorded. CONCLUSIONS: At centers with expertise in testicular cancer and minimally invasive surgery, in appropriately selected patients robotic PC-RPLND is associated with comparable short-term oncological outcomes to the open approach. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e691 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Alireza Ghoreifi More articles by this author Anirban Mitra More articles by this author Ashish Khanna More articles by this author Jordan Rich More articles by this author George McClintock More articles by this author Fady Baky More articles by this author Zachary Mcdowell More articles by this author Matthew Ho More articles by this author Jacob Roberts More articles by this author Farshad Sheybaee Moghaddam More articles by this author Taseen Haque More articles by this author Inderbir Gill More articles by this author Scott Eggener More articles by this author James Porter More articles by this author Nariman Ahmadi More articles by this author Reza Mehrazin More articles by this author John Sfakianos More articles by this author Aditya Bagrodia More articles by this author Sudhir Rawal More articles by this author John Ward More articles by this author Hooman Djaladat More articles by this author Expand All Advertisement PDF downloadLoading ...